Impel Pharmaceuticals Inc

IMPLCIK 0001445499 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Mar 31, 2023. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0066

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Mar 12, 2024no items parsed Feb 14, 2024no items parsed Jan 2, 2024no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Impel Pharmaceuticals Inc

Name	Roles	Filings
Cline Darren S	Director	2
Hoekman John	Officer	2
Paolillo Leonard	Officer	2
Shah Mahendra	Director	2
Shrewsbury Stephen B	Officer	2

Showing 6-10 of 37

Per pagePrevPage 2 of 8Next

All filings

30 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Apr 9, 2024	Allison David D. Director	Holdings only	-	-	-
Apr 9, 2024	Nelson Timothy S Director	JOther	10,000	$0.00	$0
Apr 9, 2024	Wilfong Diane E. Director	Holdings only	-	-	-
Dec 19, 2023	Vivo Capital VIII, LLC 10% Owner	SSale	87,934	$0.29	$25,501
Dec 4, 2023	Oaktree-Tcdrs Strategic Credit, LLC 10% Owner	Holdings only	-	-	-

Showing 1-5 of 30

Per pagePage 1 of 6Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value